Heska Corporation
HSKA
$119.99
Share price
0.00%
Change (1 day)
29.80%
Change (1 year)
Categories
P/S ratio for Heska Corporation (HSKA)
P/S ratio as of September 2023 (TTM): 5.14
According to Heska Corporation 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.13773. At the end of 2023 the company had a P/S ratio of 4.21.
P/S ratio history for Heska Corporation from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.21 | 61.07% |
| 2022 | 2.62 | -66.05% |
| 2021 | 7.70 | 10.13% |
| 2020 | 6.99 | 13.45% |
| 2019 | 6.16 | 18.89% |
| 2018 | 5.19 | 17.97% |
| 2017 | 4.40 | 15.77% |
| 2016 | 3.80 | 54.97% |
| 2015 | 2.45 | 91.42% |
| 2014 | 1.28 | 96.69% |
| 2013 | 0.6507 | 8.87% |
| 2012 | 0.5977 | 9.49% |
| 2011 | 0.5459 | 37.7% |
| 2010 | 0.3964 | 9.04% |
| 2009 | 0.3636 | 129.07% |
| 2008 | 0.1587 | -86.12% |
| 2007 | 1.14 | 0.64% |
| 2006 | 1.14 | 21.14% |
| 2005 | 0.9379 | 10.08% |
| 2004 | 0.8521 | -50.41% |
| 2003 | 1.72 | 427.09% |
| 2002 | 0.3260 | -67.1% |
| 2001 | 0.9908 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 3.93 | -23.56% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.33 | -54.74% | 🇺🇸 USA |
 Eli Lilly LLY | 17.7 | 244.15% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | 10.3 | 100.86% | 🇺🇸 USA |
 Zoetis ZTS | 9.78 | 90.35% | 🇺🇸 USA |
 Merck MRK | 4.52 | -11.96% | 🇺🇸 USA |
 Petco WOOF | 0.1690 | -96.71% | 🇺🇸 USA |